Farms.com Home   News

Chorney Prepares To Join Canadian Grain Commission

 
Former Keystone Agricultural Producers (KAP) president and East Selkirk farmer Doug Chorney is looking forward to his appointment to the Canadian Grain Commission (CGC), which starts on Monday, February 13.
 
Chorney will serve as the agency's assistant chief commissioner.
 
He noted his experience with KAP taught him a lot about how the CGC works.
 
“Now I'm going to be given an opportunity to be part of that process. I think it's going to be a natural transition for me. I understand the role of being a regulator, but I also understand that the reason the CGC exists, for the most part, is to protect producers and that's always top of mind for me."
 
Chorney said he had to step down from his current positions with Manitoba Agricultural Services Corporation (MASC) and with the Canadian Agricultural Human Resource Council, adding the CGC appointment will be a full time commitment for the next five years.
 
Source : Steinbachonline

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.